Functional imaging of HER2-positive metastatic breast cancer using 64Cu DOTA-trastuzumab positron emission tomography (PET)

被引：0
|
作者：
Mortimer, Joanne E.
Conti, Peter
Tong, Shan
Reyes, Jose
Carroll, Mary I.
Poku, Kofi
Colcher, David
Raubitschek, Andrew Antony
Bading, James R.
Miles, Joshua
机构：
[1] City Hope Canc Ctr, Beckman Res Inst, Duarte, CA USA
[2] USC, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
639
引用
收藏
页数：1
相关论文
共 50 条
  • [1] 64Cu DOTA-trastuzumab (64Cu-Herceptin)/PET effectively visualizes metastatic breast cancer in HER2-positive patients
    Bading, J.
    Conti, Peter
    Tong, Shan
    Reyes, J.
    Carroll, Mary
    Poku, Erasmus
    Miles, Joshua
    Colcher, David
    Raubitschek, Andrew
    Mortimer, Joanne
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [2] Correlation of 64Cu DOTA-trastuzumab positron emission tomography (PET) imaging with HER2 status by immunohistochemistry (IHC).
    Mortimer, Joanne E.
    Bading, James R.
    Carroll, Mary I.
    Tri Tran
    Park, Jinha Mark
    Cher, David Co
    Raubitschek, Andrew Antony
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] 64Cu-DOTA-trastuzumab-PET imaging in patients with HER2-positive breast cancer
    Tamura, Kenji
    Kurihara, Hiroaki
    Yonemori, Kan
    Takahashi, Kazuhiro
    Wada, Yasuhiro
    Hasegawa, Koki
    Koizumi, Fumiaki
    Tsuda, Hitoshi
    Kodaira, Makoto
    Yunokawa, Mayu
    Shimizu, Chikako
    Ando, Masashi
    Watanabe, Yasuyoshi
    Fujiwara, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] 64CU-DOTA-TRASTUZUMAB-PET IMAGING IN PATIENTS WITH HER2-POSITIVE BREAST CANCER
    Tamura, K.
    Yonemori, K.
    Kurihara, H.
    Kodaira, M.
    Yunokawa, M.
    Shimizu, C.
    Ando, M.
    Fujiwara, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 40 - 40
  • [5] 64Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer
    Tamura, Kenji
    Kurihara, Hiroaki
    Yonemori, Kan
    Tsuda, Hitoshi
    Suzuki, Junko
    Kono, Yuzuru
    Honda, Natsuki
    Kodaira, Makoto
    Yamamoto, Harukaze
    Yunokawa, Mayu
    Shimizu, Chikako
    Hasegawa, Koki
    Kanayama, Yousuke
    Nozaki, Satoshi
    Kinoshita, Takayuki
    Wada, Yasuhiro
    Tazawa, Shusaku
    Takahashi, Kazuhiro
    Watanabe, Yasuyoshi
    Fujiwara, Yasuhiro
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (11) : 1869 - 1875
  • [6] The feasibility study of 64Cu-DOTA-trastuzumab PET imaging in patients with HER2-positive breast cancer
    Yonemori, Kan
    Tamura, Kenji
    Kurihara, Hiroaki
    Kono, Yuzuru
    Arai, Yasuaki
    Wada, Yasuhiro
    Takahashi, Kazuhiro
    Hasegawa, Koki
    Watanabe, Yasuyoshi
    Fujiwara, Yasuhiro
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [7] 64Cu-DOTA-trastuzumab positron emission tomography imaging of HER2 in women with advanced breast cancer
    Mortimer, J. E.
    Conti, P.
    Shan, T.
    Carroll, M.
    Kofi, P.
    Colcher, D.
    Raubitschek, A. A.
    Bading, J. R.
    Miles, J.
    CANCER RESEARCH, 2012, 72
  • [8] 64Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patients
    Hiroaki Kurihara
    Akinobu Hamada
    Masayuki Yoshida
    Schuichi Shimma
    Jun Hashimoto
    Kan Yonemori
    Hitomi Tani
    Yasuji Miyakita
    Yousuke Kanayama
    Yasuhiro Wada
    Makoto Kodaira
    Mayu Yunokawa
    Harukaze Yamamoto
    Chikako Shimizu
    Kazuhiro Takahashi
    Yasuyoshi Watanabe
    Yasuhiro Fujiwara
    Kenji Tamura
    EJNMMI Research, 5
  • [9] 64Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patients
    Kurihara, Hiroaki
    Hamada, Akinobu
    Yoshida, Masayuki
    Shimma, Schuichi
    Hashimoto, Jun
    Yonemori, Kan
    Tani, Hitomi
    Miyakita, Yasuji
    Kanayama, Yousuke
    Wada, Yasuhiro
    Kodaira, Makoto
    Yunokawa, Mayu
    Yamamoto, Harukaze
    Shimizu, Chikako
    Takahashi, Kazuhiro
    Watanabe, Yasuyoshi
    Fujiwara, Yasuhiro
    Tamura, Kenji
    EJNMMI RESEARCH, 2015, 5
  • [10] Imaging HER-2 positive breast cancer tumors with trastuzumab radiolabeled with DOTA, Oxo and PCTA and positron emission tomography (PET)
    Yapp, Donald T.
    Ferreira, Cara L.
    Crisp, Sarah
    Sutherland, Brent
    Ng, Sylvia S. W.
    Gleave, Martin
    Bensimon, Corinne
    Jurek, Paul
    Kiefer, Garry E.
    CANCER RESEARCH, 2010, 70
12345